Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease Trial Phase 1 Not yet recruiting Sept. 20, 2026
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months. Trial Phase 2 Recruiting Sept. 20, 2026
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Trial N/A Suspended Sept. 20, 2026
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism Trial N/A Not yet recruiting Sept. 17, 2026
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease Trial N/A Recruiting Sept. 17, 2026
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) Trial Phase 1 Active, not recruiting Sept. 17, 2026
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control Trial N/A Recruiting Sept. 17, 2026
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease Trial Phase 1 Recruiting Sept. 17, 2026